Okami Medical Closes $45 Million Financing Round
Okami Medical, a leading innovator in medical technology, has successfully raised $45 million in a financing round that garnered immense investor interest. This funding was primarily led by Gilde Healthcare, a new participant in Okami’s venture, with additional contributions from existing investors such as Vensana Capital and U.S. Venture Partners.
Purpose of the Financing
The funds from this impressive financing round are strategically aimed at expanding Okami Medical's commercial operations and advancing its clinical programs. This aligns with the company’s commitment to enhancing healthcare outcomes for patients affected by vascular diseases. The investment is also intended to fuel the continued development of Okami's innovative devices designed to occlude peripheral vessels effectively.
New Leadership to Propel Growth
As part of this development, Drew Hykes, who previously held the role of CEO at Inari Medical, has been appointed as the President and CEO of Okami Medical. Alongside him, Bill Hoffman assumes the position of Chairman of the Board. Hykes expressed his excitement about joining Okami, praising the LOBO vascular occluder's clinical versatility and performance across diverse anatomies.
Expert Board Composition Enhances Strategy
In addition to leadership changes, Gilde Healthcare’s Geoff Pardo and Susana Amorim have joined Okami Medical's Board of Directors. Pardo remarked on Gilde’s long-standing interest in Okami, citing the company’s robust technology and significant market potential. He emphasized their enthusiasm for collaborating with Hykes and the highly skilled team at Okami to drive forward its mission of transforming patient care.
About Okami Medical
Okami Medical is dedicated to stopping the flow of vascular complications and restoring lives. Established in 2017, Okami Medical focuses on developing innovative medical devices that cater to the ever-evolving needs of both patients and healthcare professionals. Through their commitment and passion, they strive to improve the quality of treatment for those suffering from vascular conditions.
About Gilde Healthcare
Gilde Healthcare is a prominent healthcare investment firm managing €2.6 billion across various fund strategies, including venture and private equity. Their mission is to support fast-growing companies in therapeutics, medical technology, and digital health industries across Europe and North America.
About Vensana Capital
Vensana Capital specializes in partnering with entrepreneurs focused on innovative breakthroughs in healthcare. With around $1 billion in capital under management, Vensana is actively investing in promising growth-stage companies within the medical technology sector, including medical devices and data-driven healthcare solutions.
Frequently Asked Questions
What was the purpose of Okami Medical's recent financing?
The financing is intended to expand Okami Medical's commercial operations and facilitate the advancement of its clinical programs aimed at improving outcomes for patients with vascular diseases.
Who has been appointed as the new CEO of Okami Medical?
Drew Hykes, formerly the CEO of Inari Medical, has been appointed as the new President and CEO of Okami Medical.
What is the LOBO vascular occluder?
The LOBO vascular occluder is a medical device developed by Okami Medical that is designed for the occlusion of peripheral blood vessels across various anatomies.
How does Gilde Healthcare fit into Okami Medical's strategy?
Gilde Healthcare is a key investor and partner in Okami Medical, bringing expertise and resources to enhance the company's growth and strategic initiatives.
What distinguishes Okami Medical in the medical technology field?
Okami Medical is recognized for its commitment to innovation in vascular embolization solutions, focusing on versatile and intuitive devices that meet the needs of patients and healthcare providers.
